Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 27, 2026
Principal Financial Group (PFG) Q2 2026 Earnings Preview: Strong +26% YTD Gains Set the Stage

Principal Financial Group (PFG) Q2 2026 Earnings Preview: Strong +26% YTD Gains Set the Stage

Key Takeaways

  • Principal Financial Group (PFG) is scheduled to report second quarter 2026 financial results after U.S. markets close on Monday, July 27, with a conference call set for Tuesday, July 28, at 10 a.m. ET.
  • Wall Street consensus projects earnings of approximately $2.32 per share, representing year-over-year growth of roughly 7.4% from the $2.16 reported in the same quarter last year.
  • Revenue expectations center around $4.06 billion to $4.11 billion, implying an increase of approximately 10% to 11% compared with $3.69 billion in Q2 2025.
  • The stock enters earnings with strong upward momentum, having gained roughly 26% year-to-date, though it has pulled back modestly from its 52-week high of $114.90 reached in mid-July.
  • First quarter 2026 results exceeded expectations, with non-GAAP operating earnings per share excluding significant variances reaching $2.17, up 13% from the prior-year period, sending the stock 2.4% higher the following day.
  • The company's earnings surprise track record is mixed — PFG has beaten consensus estimates in two of its last four quarterly reports while missing on the other two.

Earnings Context and Why It Matters

Principal Financial Group (PFG), the 146-year-old Des Moines, Iowa-based financial services firm, is approaching its second-quarter 2026 report with solid momentum. Its diversified model across retirement solutions, asset management, and benefits and protection has supported double-digit earnings growth and margin expansion recently. With roughly $770 billion in assets under management (AUM) and about $1.8 trillion in assets under administration (AUA), the results offer insight into retirement trends, small and midsize business conditions, and institutional demand. I’m watching closely to see whether the first-quarter strength in retirement transfer deposits, record asset management sales, and favorable underwriting carried forward.

Earnings Expectations

Analysts expect PFG to post earnings of $2.32 per share for the second quarter, up from $2.16 in Q2 2025. Revenue consensus stands near $4.11 billion, an 11.4% rise from $3.69 billion a year earlier, though some estimates sit closer to $4.06 billion. The EPS consensus has edged about 1% higher over the past month, indicating slightly more constructive views. To cross-check sector peers, I also checked this using Tickeron’s AI Screener.

Component forecasts include $1.11 billion in fees and other revenues, $1.30 billion in net investment income, and around $1.65 billion in premiums and other considerations. Within Principal Asset Management, fee revenues are projected near $555 million. The Benefits and Protection segment’s Specialty Benefits division is expected to generate about $933 million in revenue, including roughly $868 million in premiums.

Investors will focus on net cash flow trends, the total loss ratio in Benefits and Protection, non-GAAP operating return on equity (which hit 16.1% in Q1 2026, within the 15% to 17% target range), and capital deployment. PFG raised its quarterly dividend to $0.82 per share, an 8% increase year-over-year, and repurchased $200 million in shares in the first quarter.

Market Reaction and Investor Sentiment

PFG shares closed at $109.40 on July 24, about 4.8% below the 52-week high of $114.90 reached on July 14. The recent pullback reflects some caution, yet the stock remains up approximately 26% year-to-date, ahead of broader averages. The forward dividend yield is near 3.0% with the increased $0.82 quarterly payout.

Analyst views are neutral to moderately constructive, with a consensus Hold rating from 12 analysts and an average 12-month price target around $106. Targets have been rising, however: Piper Sandler lifted its target to $125 with an Overweight rating in late June, while Raymond James raised its to $111 with an Outperform rating in May. The Zacks Earnings ESP of +0.29% points to a modestly favorable setup, though the mixed surprise history leaves no strong directional bias.

Potential risks include higher claims in Benefits and Protection, weaker variable net investment income, foreign exchange impacts, or slower demand for retirement products. Positive factors would include further margin expansion, strong AUM-driven fee growth, and disciplined expenses.

Forward Outlook and Key Factors to Monitor

Management remains confident in its full-year 2026 targets following the 13% adjusted non-GAAP EPS growth in the first quarter. During the Q1 call, leadership noted that items like performance fees, real estate gains, and net cash flows can be lumpy. Investors should listen for any updates to the 15% to 17% non-GAAP operating ROE target and variable investment income expectations.

Retirement and asset management flows will be key. In Q1, retirement transfer deposits rose 35% year-over-year to $12 billion, and Principal Asset Management recorded record gross sales of $37 billion, up 21%. Sustained momentum here would signal competitive strength and healthy demand.

On the insurance side, the Benefits and Protection segment improved its total loss ratio by 220 basis points in Q1, with Specialty Benefits posting record sales. Continued favorable underwriting and premium growth in the small-to-midsize business market would bolster overall results. Excess and available capital exceeded $1.4 billion at the end of Q1, including about $800 million at the holding company, so updates on capital deployment, including share repurchases, will matter.

Macro factors such as interest rates, credit spreads, and equity market levels will influence investment income and AUM. The diversified business mix offers some buffer, but these variables remain relevant for the second half of 2026.

Using AI Tools for Deeper Analysis

In my research process, I frequently turn to Tickeron’s AI Screener to scan the financial services sector and compare PFG against peers on metrics like valuation, momentum, and AI signals. The platform’s customizable filters help surface ideas quickly without hours of manual work, which is especially useful around earnings season when I want a broader context for individual reports like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PFG

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


PFG in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 22, 2026

PFG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where PFG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFG advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 299 cases where PFG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where PFG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PFG as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PFG turned negative on August 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.006) is normal, around the industry mean (3.569). P/E Ratio (16.207) is within average values for comparable stocks, (27.541). PFG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.269). Dividend Yield (0.028) settles around the average of (0.086) among similar stocks. P/S Ratio (1.607) is also within normal values, averaging (17.979).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. PFG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.98B. The market cap for tickers in the group ranges from 57 to 179.79B. BLK holds the highest valuation in this group at 179.79B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2%. CWD experienced the highest price growth at 46%, while BENF experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 78% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 57
Price Growth Rating: 54
SMR Rating: 74
Profit Risk Rating: 77
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
PFG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of retirement plans, asset management and insurance services

Industry InvestmentManagers

Profile
Details
Industry
Life Or Health Insurance
Address
711 High Street
Phone
+1 515 247-5111
Employees
19700
Web
https://www.principal.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.